Tongnuokang Biotech

同诺康

Tongnuokang Biotech

Biotech/Healthcare

Tongnuokang is guided by unmet clinical needs and focuses on genomic vulnerability targets, including synthetic lethality, chromosomal instability, and whole-genome doubling. It integrates proprietary AI, biological data mining, and high-throughput screening technologies throughout the drug…

Latest round: Angel (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-11-01